PET imaging with [18F]fluoroethoxybenzovesamicol ([18F]FEOBV) following selective lesion of cholinergic pedunculopontine tegmental neurons in rat

Nuclear Medicine and Biology

Volumn 41, Issue 1, 2014, Pages 96-101

  Cyr, Marilyn ^a,b   Parent, Maxime J ^a,b   Mechawar, Naguib ^b   Rosa Neto, Pedro ^b,c   Soucy, Jean Paul ^c   Aliaga, Antonio ^c   Kostikov, Alexey ^c   Maclaren, Duncan A A ^d,e   Clark, Stewart D ^e   Bedard, Marc Andre ^a,b,c  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF ST ANDREWS   (United Kingdom)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

18F fluoroethoxybenzovesamicol ( 18F FEOBV); Acetylcholine; Immunocytochemistry; Pedunculopontine tegmental nucleus (PPTg); Positron emission tomography (PET); Vesicular acetylcholine transporter

Indexed keywords

FLUOROETHOXYBENZOVESAMICOL F 18; TRACER; UNCLASSIFIED DRUG; ACETYLCHOLINE; DIAGNOSTIC AGENT; FLUOROETHOXY BENZOVESAMICOL; FLUOROETHOXY-BENZOVESAMICOL; PIPERIDINE DERIVATIVE; VESICULAR ACETYLCHOLINE TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CELL DENSITY; CELL LOSS; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG SYNTHESIS; EX VIVO STUDY; GLOBUS PALLIDUS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NERVE CELL LESION; NERVE PROJECTION; NEUROANATOMY; NEUROIMAGING; NONHUMAN; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; POSITRON EMISSION TOMOGRAPHY; RAT; THALAMUS; [(18)F]FLUOROETHOXYBENZOVESAMICOL ([(18)F]FEOBV); ANIMAL; CYTOLOGY; PEDUNCULOPONTINE TEGMENTAL NUCLEUS (PPTG); POSITRON EMISSION TOMOGRAPHY (PET); SCINTISCANNING;

[(18)F]FLUOROETHOXYBENZOVESAMICOL ([(18)F]FEOBV); ACETYLCHOLINE; IMMUNOCYTOCHEMISTRY; PEDUNCULOPONTINE TEGMENTAL NUCLEUS (PPTG); POSITRON EMISSION TOMOGRAPHY (PET); VESICULAR ACETYLCHOLINE TRANSPORTER;

ANIMALS; CHOLINERGIC NEURONS; MALE; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY; RATS;

EID: 84888383249     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.10.004     Document Type: Article

References (51)

1. Benarroch E.E. Acetylcholine in the cerebral cortex: effects and clinical implications. Neurology 2010, 75:659-665.
2. Winn P. How best to consider the structure and function of the pedunculopontine tegmental nucleus: evidence from animal studies. J Neurol Sci 2006, 248:234-250.
3. Sarter M., Hasselmo M.E., Bruno J.P., Givens B. Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res Brain Res Rev 2005, 48:98-111.
4. Winn P. Frontal syndrome as a consequence of lesions in the pedunculopontine tegmental nucleus: a short theoretical review. Brain Res Bull 1998, 47:551-563.
5. Auld D.S., Kornecook T.J., Bastianetto S., Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 2002, 68:209-245.
6. Mufson E.J., Ma S.Y., Cochran E.J., Bennett D.A., Beckett L.A., Jaffar S., et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 2000, 427:19-30.
7. Londos E., Passant U., Risberg J., Gustafson L., Brun A. Contributions of other brain pathologies in dementia with lewy bodies. Dement Geriatr Cogn Disord 2002, 13:130-148.
8. Kosaka K., Yoshimura M., Ikeda K., Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease?. Clin Neuropathol 1984, 3:185-192.
9. Jellinger K. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1988, 51:540-543.
10. Gilman S., Koeppe R.A., Nan B., Wang C.N., Wang X., Junck L., et al. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology 2010, 74:1416-1423.
11. Benarroch E.E., Schmeichel A.M., Parisi J.E. Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy. Neurology 2002, 59:944-946.
12. 18F]FP-TZTP. Nucl Med Biol 2012, 39:45-55.
13. 18F-nifene kinetics in the nonhuman primate. J Nucl Med 2012, 53:1471-1480.
14. Pappata S., Tavitian B., Traykov L., Jobert A., Dalger A., Mangin J.F., et al. In vivo imaging of human cerebral acetylcholinesterase. J Neurochem 1996, 67:876-879.
15. Giboureau N., Som I.M., Boucher-Arnold A., Guilloteau D., Kassiou M. PET radioligands for the vesicular acetylcholine transporter (VAChT). Curr Top Med Chem 2010, 10:1569-1583.
16. 18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse 1998, 30:263-274.
17. 18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter. Nucl Med Biol 2009, 36:489-493.
18. 18F]-FEOBV in rat: a promising tracer for imaging cholinergic innervation densities. Can J Neurol Sci 2008, 35:S46.
19. 18F]-FEOBV in rat: results and implications for clinical applications. Can J Neurol Sci 2008, 35:S46-S47.
20. 18F-FEOBV PET: development of a tool to assess cholinergic losses in Alzheimer's disease. Alzheimers Dement 2010, 6:S286.
21. 18)F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter. Synapse 2007, 61:962-970.
22. 18F]FEOBV). NeuroImage 2012, 62:555-561.
23. 18F]Fluoroethoxy-benzovesamicol and micro-PET. J Cereb Blood Flow Metab 2007, 27:3M-7M.
24. Mesulam M.M., Mufson E.J., Wainer B.H., Levey A.I. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 1983, 10:1185-1201.
25. Mesulam M.M., Geula C., Bothwell M.A., Hersh L.B. Human reticular formation: cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J Comp Neurol 1989, 283:611-633.
26. Hallanger A.E., Levey A.I., Lee H.J., Rye D.B., Wainer B.H. The origins of cholinergic and other subcortical afferents to the thalamus in the rat. J Comp Neurol 1987, 262:105-124.
27. Lavoie B., Parent A. Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods. J Comp Neurol 1994, 344:210-231.
28. Scarnati E., Florio T. The Pedunculopontine Nucleus and Related Structures. The Basal Ganglia and New Surgical Approaches for Parkison's Disease, Advances in Neurology 1997, Lippincott-Raven Publishers, Philadelphia. J.A. Obeso, M.R. DeLong, C. Ohye, C.D. Marsden (Eds.).
29. Clark S.D., Alderson H.L., Winn P., Latimer M.P., Nothacker H.P., Civelli O. Fusion of diphtheria toxin and urotensin II produces a neurotoxin selective for cholinergic neurons in the rat mesopontine tegmentum. J Neurochem 2007, 102:112-120.
30. Cyr M., MacLaren D.A., Bedard M.A., Clark S.D., Mechawar N., Winn P. Highly selective lesion of the cholinergic pedunculopontine neurons using a minimally-invasive angular stereotaxic surgery with the Diphteria-Urotensin-II neurotoxin in rat. Program No 3706/C47 2011 Neuroscience Meeting Planner Washington 2011, Society for Neuroscience, DC.
31. Whishaw I.Q., Cioe J.D., Previsich N., Kolb B. The variability of the interaural line vs the stability of bregma in rat stereotaxic surgery. Physiol Behav 1977, 19:719-722.
32. Wilson D.I., MacLaren D.A., Winn P. Bar pressing for food: differential consequences of lesions to the anterior versus posterior pedunculopontine. Eur J Neurosci 2009, 30:504-513.
33. 18F]FEOBV and in vivo PET imaging of acetylcholine vesicular transporter in the rat. J Cereb Blood Flow Metab 2007, 27. [10-7U].
34. 18F]fluoroethoxy-benzovesamicol, a radiotracer for cholinergic neurons. J Label Compd Radiopharm 1993, 33:583-591.
35. Rubins D.J., Melega W.P., Lacan G., Way B., Plenevaux A., Luxen A., et al. Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain. NeuroImage 2003, 20:2100-2118.
36. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996, 16:834-840.
37. De Bartolo P., Gelfo F., Mandolesi L., Foti F., Cutuli D., Petrosini L. Effects of chronic donepezil treatment and cholinergic deafferentation on parietal pyramidal neuron morphology. J Alzheimers Dis 2009, 17:177-191.
38. Schafer M.K., Weihe E., Varoqui H., Eiden L.E., Erickson J.D. Distribution of the vesicular acetylcholine transporter (VAChT) in the central and peripheral nervous systems of the rat. J Mol Neurosci 1994, 5:1-26.
39. Mechawar N., Cozzari C., Descarries L. Cholinergic innervation in adult rat cerebral cortex: a quantitative immunocytochemical description. J Comp Neurol 2000, 428:305-318.
40. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2009, Academic Press, San Diego. 6th ed.
41. Sugimoto T., Hattori T. Organization and efferent projections of nucleus tegmenti pedunculopontinus pars compacta with special reference to its cholinergic aspects. Neuroscience 1984, 11:931-946.
42. Beninato M., Spencer R.F. A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus. Brain Res 1987, 412:169-174.
43. Woolf N.J., Butcher L.L. Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain. Brain Res Bull 1986, 16:603-637.
44. Wang H.L., Morales M. Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci 2009, 29:340-358.
45. Kita T., Kita H. Cholinergic and non-cholinergic mesopontine tegmental neurons projecting to the subthalamic nucleus in the rat. Eur J Neurosci 2011, 33:433-443.
46. Lavoie B., Parent A. Pedunculopontine nucleus in the squirrel monkey: cholinergic and glutamatergic projections to the substantia nigra. J Comp Neurol 1994, 344:232-241.
47. Di Loreto S., Florio T., Scarnati E. Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons. Exp Brain Res 1992, 89:79-86.
48. Worsley K.J., Marrett S., Neelin P., Vandal A.C., Friston K.J., Evans A.C. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 1996, 4:58-73.
49. Sofroniew M.V., Priestley J.V., Consolazione A., Eckenstein F., Cuello A.C. Cholinergic projections from the midbrain and pons to the thalamus in the rat, identified by combined retrograde tracing and choline acetyltransferase immunohistochemistry. Brain Res 1985, 329:213-223.
50. Semba K., Reiner P.B., McGeer E.G., Fibiger H.C. Brainstem afferents to the magnocellular basal forebrain studied by axonal transport, immunohistochemistry, and electrophysiology in the rat. J Comp Neurol 1988, 267:433-453.
51. 18F]Fluoroethoxybenzovesamicol Autoradiography. Metabolism 2012, 32:S72-S73.